Modelling occult lymph node metastases in HNSCC patients with a trinary state hidden Markov model.

IF 3.3 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Yoel Samuel Pérez Haas, Roman Ludwig, Esmée Lauren Looman, Vincent Grégoire, Panagiotis Balermpas, Jan Unkelbach
{"title":"Modelling occult lymph node metastases in HNSCC patients with a trinary state hidden Markov model.","authors":"Yoel Samuel Pérez Haas, Roman Ludwig, Esmée Lauren Looman, Vincent Grégoire, Panagiotis Balermpas, Jan Unkelbach","doi":"10.1088/1361-6560/adc235","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Head-and-neck squamous cell carcinoma frequently metastasize through lymphatic system. Occult metastases are challenging for designing radiotherapy treatment volumes. Literature values indicate that around 20% of lymph node metastases are clinically undetected. However, recent data suggest that this value is only representative for level II whereas the rate of occult metastases is substantially higher in levels III and IV. , while occult metastases are more common in levels III and IV.</p><p><strong>Approach: </strong>We propose a trinary-state Hidden Markov Model to describe ipsilateral lymphatic tumor progression over time. Each lymph node level (LNL) can be in one of three states: healthy, microscopically (pathologically) involved, or macroscopically (clinically) involved. In each time step, a healthy LNL may become microscopically involved due to spread from the primary tumor or an involved upstream LNL. In addition, a microscopically involved LNL may transition to macroscop- ically involved. The probability of occult metastases is obtained as the conditional probability of being in the microscopically involved state given the individual patient's macroscopic involvement. Model parameters are learned from a dataset of 550 patients, including 263 with both pathological and clinical LNL involvement reported.</p><p><strong>Main results: </strong>For oropharyngeal SCC, the model estimates an occult metastases probability below 5% in LNL IV unless LNL III is clinically positive, suggesting potential for reducing elective clinical target volumes. The model's estimated rate of clinically undetected metastases is 82%, 41%, and 34% for LNL II, III, and IV, respectively, which agrees with the data.</p><p><strong>Significance: </strong>The proposed trinary-state HMM represents a methodological extension to a previ- ously published binary-state HMM. The binary HMM distinguished the microscopic and macroscopic involvement via the concept of sensitivity, which may underestimate the risk of occult metastases. The trinary HMM addresses this problem and represents a more natural description of tumor progression.</p>","PeriodicalId":20185,"journal":{"name":"Physics in medicine and biology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics in medicine and biology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1088/1361-6560/adc235","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Head-and-neck squamous cell carcinoma frequently metastasize through lymphatic system. Occult metastases are challenging for designing radiotherapy treatment volumes. Literature values indicate that around 20% of lymph node metastases are clinically undetected. However, recent data suggest that this value is only representative for level II whereas the rate of occult metastases is substantially higher in levels III and IV. , while occult metastases are more common in levels III and IV.

Approach: We propose a trinary-state Hidden Markov Model to describe ipsilateral lymphatic tumor progression over time. Each lymph node level (LNL) can be in one of three states: healthy, microscopically (pathologically) involved, or macroscopically (clinically) involved. In each time step, a healthy LNL may become microscopically involved due to spread from the primary tumor or an involved upstream LNL. In addition, a microscopically involved LNL may transition to macroscop- ically involved. The probability of occult metastases is obtained as the conditional probability of being in the microscopically involved state given the individual patient's macroscopic involvement. Model parameters are learned from a dataset of 550 patients, including 263 with both pathological and clinical LNL involvement reported.

Main results: For oropharyngeal SCC, the model estimates an occult metastases probability below 5% in LNL IV unless LNL III is clinically positive, suggesting potential for reducing elective clinical target volumes. The model's estimated rate of clinically undetected metastases is 82%, 41%, and 34% for LNL II, III, and IV, respectively, which agrees with the data.

Significance: The proposed trinary-state HMM represents a methodological extension to a previ- ously published binary-state HMM. The binary HMM distinguished the microscopic and macroscopic involvement via the concept of sensitivity, which may underestimate the risk of occult metastases. The trinary HMM addresses this problem and represents a more natural description of tumor progression.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Physics in medicine and biology
Physics in medicine and biology 医学-工程:生物医学
CiteScore
6.50
自引率
14.30%
发文量
409
审稿时长
2 months
期刊介绍: The development and application of theoretical, computational and experimental physics to medicine, physiology and biology. Topics covered are: therapy physics (including ionizing and non-ionizing radiation); biomedical imaging (e.g. x-ray, magnetic resonance, ultrasound, optical and nuclear imaging); image-guided interventions; image reconstruction and analysis (including kinetic modelling); artificial intelligence in biomedical physics and analysis; nanoparticles in imaging and therapy; radiobiology; radiation protection and patient dose monitoring; radiation dosimetry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信